Reduced incidence of kaposi's sarcoma and of systemic non‐hodgkin's lymphoma in HIV‐infected individuals treated with highly active antiretroviral therapy
Open Access
- 26 November 2002
- journal article
- letter
- Published by Wiley in International Journal of Cancer
- Vol. 103 (1) , 142-144
- https://doi.org/10.1002/ijc.10790
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Impact of Highly Active Antiretroviral Therapy on Individual AIDS-Defining Illness Incidence and Survival in AustraliaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapyBlood, 2001
- AIDS and cancer in the era of highly active antiretroviral therapy (HAART)European Journal Of Cancer, 2001
- Highly Active Antiretroviral Therapy and Incidence of Cancer in Human Immunodeficiency Virus-Infected AdultsJNCI Journal of the National Cancer Institute, 2000
- AIDS across Europe, 1994–98: the EuroSIDA studyThe Lancet, 2000
- Incidence and Trends in Kaposi's Sarcoma in the Era of Effective Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Incidence and Trends in Kaposi's Sarcoma in the Era of Effective Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Cancer risk among men with, or at risk of, HIV infection in southern EuropeAIDS, 2000
- AIDS-Related Opportunistic Illnesses Occurring After Initiation of Potent Antiretroviral TherapyJAMA, 1999